Paola Bianchi
Italy
Dr. Paola Bianchi - Fondation IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan – Italy
Head Biologist at the Physiopathology of Anemias Unit, and Clinical Pathology Unit, Foundation
IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan,Italy.
Diagnosis and translational research on hemolytic anemias, both congenital and acquired and
mieloproliferative disorders.
She shared National and International projects on molecular characterization and genotype –
phenotype correlation, and on the epigenetic factors that might influence clinical phenotype. By
NGS approaches she identified new genes responsible for rare forms of hemolytic anemia.
2018-2023 Member of EHA Guidelines steering committee
2017-present ERN-EuroBloodNet (member of RADeep Steering Committee, Member of Guidelines
committee)
2023- present Substitute representative European Reference Network for Fondazione IRCCS Ca’
Granda Ospedale Maggiore Policlinico
2020-present Member of Steering committee International PK deficiency Peak Registry, and Italian
ISS PNH registry.
2022-2024 Co-chair of the European Red cell Society.
2025-pres. President of STEM Association (Studio e Trattamento del Malato Ematologico)
Author and co-authors of more than 140 papers on peer-review international journals and of book
chapters on rare anemias.
10:30 – 12:20
Wednesday Day 3 : May 6th
Scientific Session 5 – Red Cell Membrane Biology in Health and Disease
CHAIRS : Richard van Wijk, Hélène Guizouarn
10:30 – 10:55 Invited speaker: Paola Bianchi (Italy)
Breaking the Balance: Red Blood Cell Instability in Hereditary Spherocytosis and Beyond10:55 – 11:20 Invited speaker: Loïc Garçon (France)
Expression and function of PIEZO1 during human erythropoiesis11:20 – 11:35 Guillaume Bouyer (France)
PIEZO1-driven echinocytosis in red blood cells is independent of calcium and water fluxes11:35 – 11:50 Reetta Penttinen (Germany)
Investigation of pharmacological PIEZO1 modulators using automated patch-clamp11:50 – 12:05 Bita Asghariastanehei (France)
Red blood cell PIEZO1 activation drives faster coagulation and structural alterations in blood clots through red blood cell deformability impairment12:05 – 12:20 Titine Ruiter (The Netherlands)
Ex vivo glucose tracing in red blood cells from patients with hereditary xerocytosis reveals enhanced glycolytic flux